GR3035568T3 - Yeast strains - Google Patents

Yeast strains

Info

Publication number
GR3035568T3
GR3035568T3 GR20010400414T GR20010400414T GR3035568T3 GR 3035568 T3 GR3035568 T3 GR 3035568T3 GR 20010400414 T GR20010400414 T GR 20010400414T GR 20010400414 T GR20010400414 T GR 20010400414T GR 3035568 T3 GR3035568 T3 GR 3035568T3
Authority
GR
Greece
Prior art keywords
pct
sec
yeast strains
date
protein
Prior art date
Application number
GR20010400414T
Other languages
English (en)
Inventor
Patricia Carol Wood
Alan Victor Quirk
Original Assignee
Delta Biotechnology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Delta Biotechnology Ltd filed Critical Delta Biotechnology Ltd
Publication of GR3035568T3 publication Critical patent/GR3035568T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GR20010400414T 1994-06-07 2001-03-13 Yeast strains GR3035568T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9411356A GB9411356D0 (en) 1994-06-07 1994-06-07 Yeast strains
PCT/GB1995/001317 WO1995033833A1 (en) 1994-06-07 1995-06-07 Yeast strains

Publications (1)

Publication Number Publication Date
GR3035568T3 true GR3035568T3 (en) 2001-06-29

Family

ID=10756304

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20010400414T GR3035568T3 (en) 1994-06-07 2001-03-13 Yeast strains

Country Status (14)

Country Link
US (1) US5783423A (el)
EP (1) EP0764209B1 (el)
JP (1) JP3667339B2 (el)
KR (1) KR100380532B1 (el)
AT (1) ATE198624T1 (el)
AU (1) AU698319B2 (el)
CA (1) CA2190373C (el)
DE (1) DE69519856T2 (el)
DK (1) DK0764209T3 (el)
ES (1) ES2156602T3 (el)
GB (2) GB9411356D0 (el)
GR (1) GR3035568T3 (el)
PT (1) PT764209E (el)
WO (1) WO1995033833A1 (el)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2686899B1 (fr) * 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
US6274305B1 (en) 1996-12-19 2001-08-14 Tufts University Inhibiting proliferation of cancer cells
GB9902000D0 (en) 1999-01-30 1999-03-17 Delta Biotechnology Ltd Process
US6258559B1 (en) * 1999-03-22 2001-07-10 Zymogenetics, Inc. Method for producing proteins in transformed Pichia
EP1183385B1 (en) 1999-05-21 2006-07-19 Cargill Dow LLC Methods and materials for the synthesis of organic products
US6926898B2 (en) 2000-04-12 2005-08-09 Human Genome Sciences, Inc. Albumin fusion proteins
EP1363992A1 (en) * 2001-02-26 2003-11-26 DSM IP Assets B.V. Method for increasing the intracellular glutamate concentration in yeast
US7507413B2 (en) 2001-04-12 2009-03-24 Human Genome Sciences, Inc. Albumin fusion proteins
US20050054051A1 (en) * 2001-04-12 2005-03-10 Human Genome Sciences, Inc. Albumin fusion proteins
EP1391510B1 (en) 2001-05-29 2007-09-12 Asahi Glass Company Ltd. Method of constructing host and process for producing foreign protein
US7176278B2 (en) 2001-08-30 2007-02-13 Biorexis Technology, Inc. Modified transferrin fusion proteins
CA2841097A1 (en) 2001-12-21 2003-07-24 Human Genome Sciences, Inc. Albumin and g-csf fusion proteins
WO2003059934A2 (en) 2001-12-21 2003-07-24 Human Genome Sciences, Inc. Albumin fusion proteins
WO2005003296A2 (en) 2003-01-22 2005-01-13 Human Genome Sciences, Inc. Albumin fusion proteins
US20060122374A1 (en) 2002-02-07 2006-06-08 Peter Mertins Albumin-fused anti-angiogenesis peptides
GB0217033D0 (en) 2002-07-23 2002-08-28 Delta Biotechnology Ltd Gene and polypeptide sequences
GB0224082D0 (en) * 2002-10-16 2002-11-27 Celltech R&D Ltd Biological products
US9057061B2 (en) 2003-12-23 2015-06-16 Novozymes Biopharma Dk A/S Gene expression technique
GB0329681D0 (en) * 2003-12-23 2004-01-28 Delta Biotechnology Ltd Gene expression technique
GB0329722D0 (en) 2003-12-23 2004-01-28 Delta Biotechnology Ltd Modified plasmid and use thereof
EP2330200B1 (en) 2004-12-23 2017-04-05 Albumedix A/S Gene expression technique
DK2046826T3 (da) 2006-07-24 2011-10-24 Biorexis Pharmaceutical Corp Exendin-fusionsproteiner
WO2008019368A2 (en) * 2006-08-07 2008-02-14 Teva Biopharmaceuticals Usa, Inc. Albumin-insulin fusion proteins
EP2594583A1 (en) 2007-08-08 2013-05-22 Novozymes Biopharma DK A/S Transferrin variants and conugates
US20110294988A1 (en) 2009-02-06 2011-12-01 Novozymes Bio Pharma DK A/S Purification Process
SG172789A1 (en) 2009-02-11 2011-08-29 Novozymes Biopharma Dk As Albumin variants and conjugates
WO2014138371A1 (en) 2013-03-06 2014-09-12 Glaxosmithkline Llc Host cells and methods of use
CA2919327C (en) 2013-08-09 2022-06-21 Novozymes A/S Reducing content of hexenuronic acids in cellulosic pulp
US12629445B2 (en) 2020-03-20 2026-05-19 Bard Peripheral Vascular, Inc. Reactive hydrogel forming formulations and related methods, including methods of preparation
US12161777B2 (en) 2020-07-02 2024-12-10 Davol Inc. Flowable hemostatic suspension
US11739166B2 (en) 2020-07-02 2023-08-29 Davol Inc. Reactive polysaccharide-based hemostatic agent
WO2022146917A1 (en) 2020-12-28 2022-07-07 Davol Inc. Reactive dry powdered hemostatic materials comprising a protein and a multifunctionalized modified polyethylene glycol based crosslinking agent

Also Published As

Publication number Publication date
JPH10501123A (ja) 1998-02-03
US5783423A (en) 1998-07-21
GB2302329B (en) 1998-04-29
WO1995033833A1 (en) 1995-12-14
DE69519856T2 (de) 2001-07-19
KR100380532B1 (ko) 2004-03-24
EP0764209A1 (en) 1997-03-26
PT764209E (pt) 2001-05-31
ATE198624T1 (de) 2001-01-15
DE69519856D1 (de) 2001-02-15
CA2190373C (en) 2003-01-07
GB9411356D0 (en) 1994-07-27
CA2190373A1 (en) 1995-12-14
JP3667339B2 (ja) 2005-07-06
ES2156602T3 (es) 2001-07-01
GB2302329A (en) 1997-01-15
AU698319B2 (en) 1998-10-29
AU2626295A (en) 1996-01-04
DK0764209T3 (da) 2001-03-19
EP0764209B1 (en) 2001-01-10
GB9622229D0 (en) 1996-12-18

Similar Documents

Publication Publication Date Title
GB2302329B (en) Yeast strains
PL312712A1 (en) High level expression, purification and repeated creasing of group b(porynowe?) proteins of outer membrane of neisseria meningitidis
GR3033850T3 (en) Chloropyrimide intermediates
DE69532603D1 (de) Hefestämme und modifizierte albumine
BG100974A (en) Vaccines against papillomavirus
CA2061569A1 (en) Improved activation of recombinant proteins
BG102362A (en) New derivatives of amino acids, their preparation and application
WO1997005899A3 (en) Novel vaccines and pharmaceutical compositions using membrane vesicles of microorganisms, and methods for preparing same
MX9700244A (es) Utilizacion de un poliholosido en una composicion limpiadora o desmaquillante, y composicion que lo incluye.
AU1828388A (en) Promoters for the expression of foreign dna in methylotrophic bacteria, the obtaining thereof and the use thereof
IL122606A (en) (S)-hydroxa-nitrile-lyase
NO951750L (no) Renset "nontypable" Haemophilus influenzae P5 protein som en vaksine for "nontypable" Haemophilus influenzae stamme
AU2534595A (en) Angiotensin ii for improving fertilization
IL90414A (en) Combination of angiotensin converting enzyme inhibitors with potassium channel modulators and use thereof in pharmaceuticals
SE9400524D0 (sv) Energipreparat
ZA943610B (en) Oligopeptides derived from c-reactive protein fragments
AU637589B2 (en) Ancrod proteins, their production and use
AU3893493A (en) Micro-organisms, preparation method therefor and uses thereof
AU2824289A (en) Thienotricyclene for the treatment of bronchial diseases
ZA932748B (en) Water-soluble retinoids
DE59611353D1 (de) Transketolase-verwandtes protein
AU7614798A (en) High level expression, purification and refolding of the Neisseria meningitidis outer membrane group B porin proteins
WO1994021273A3 (de) VERWENDUNG VON ANGIOGENIN UND/ODER α1-MICROGLOBULIN UND/ODER KOMPLEMENTFAKTOR D ZUR BEGRENZUNG DER SEKRETION VON PROTEINEN
UA10675A (uk) Штамм продуцеhт ліполітичhого фермеhтhого препарату солізім
MX9800686A (es) Nueva proteina hmw humana mp52s.